REQUEST A DEMO
Total
USD $0.00
Search more companies

Ifarma OOO (Russia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Ifarma OOO Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Ifarma OOO is an enterprise in Russia, with the main office in Moscow. The enterprise currently operates in the Research and Development in the Physical, Engineering, and Life Sciences sector. It was established on October 07, 2010. The total number of employees is currently 41 (2022). The latest financial highlights indicate a net sales revenue drop of 7.59% in 2023. There was a total growth of 1.04% in Ifarma OOO’s total assets over the same period. The enterprise’s net profit margin increased by 4.98% in 2023.

Headquarters
Bolishoi, 40, 3/XXXIII
Moscow; Moscow; Postal Code: 121205

Contact Details: Purchase the Ifarma OOO report to view the information.

Website: http://ipharmacovigilance.ru

Basic Information
Total Employees:
Purchase the Ifarma OOO report to view the information.
Outstanding Shares:
Purchase the Ifarma OOO report to view the information.
Registered Capital:
Purchase the Ifarma OOO report to view the information.
Incorporation Date:
October 07, 2010
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
97%
Purchase this report to view the information.
3%
Subsidiaries
Eimi OOO
97%
Company Performance
Financial values in the chart are available after Ifarma OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-7.59%
Total operating revenue
-7.59%
Operating profit (EBIT)
94.24%
Net Profit (Loss) for the Period
170.47%
Total assets
1.04%
Total equity
13.28%
Operating Profit Margin (ROS)
4.57%
Net Profit Margin
4.98%
Return on Equity (ROE)
6.82%
Quick Ratio
2.2%
Cash Ratio
1.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?